vs
Absci Corp（ABSI）与NATIONAL RESEARCH CORP（NRC）财务数据对比。点击上方公司名可切换其他公司
NATIONAL RESEARCH CORP的季度营收约是Absci Corp的54.1倍（$35.2M vs $650.0K）。NATIONAL RESEARCH CORP净利率更高（5.1% vs -4548.0%，领先4553.1%）。Absci Corp同比增速更快（-2.3% vs -4.6%）。NATIONAL RESEARCH CORP自由现金流更多（$6.1M vs $-29.3M）。过去两年NATIONAL RESEARCH CORP的营收复合增速更高（-0.2% vs -14.9%）
Absci Corp是一家结合合成生物学与人工智能技术的生物技术企业，为全球制药及生物制药合作伙伴提供集成式蛋白质工程解决方案，加速抗体、治疗性蛋白等新型生物候选药物的研发，助力满足未被覆盖的临床医疗需求。
NRC Health（原国家研究公司）是一家美国医疗健康企业，1981年成立，总部位于内布拉斯加州林肯市。公司主要在美加两国提供医疗健康相关产品及订阅式解决方案，深耕区域医疗健康服务领域。
ABSI vs NRC — 直观对比
营收规模更大
NRC
是对方的54.1倍
$650.0K
营收增速更快
ABSI
高出2.4%
-4.6%
净利率更高
NRC
高出4553.1%
-4548.0%
自由现金流更多
NRC
多$35.3M
$-29.3M
两年增速更快
NRC
近两年复合增速
-14.9%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $650.0K | $35.2M |
| 净利润 | $-29.6M | $1.8M |
| 毛利率 | — | — |
| 营业利润率 | -4775.5% | 13.3% |
| 净利率 | -4548.0% | 5.1% |
| 营收同比 | -2.3% | -4.6% |
| 净利润同比 | -2.0% | -72.6% |
| 每股收益（稀释后） | $-0.19 | $49.58 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ABSINRC
| Q4 25 | $650.0K | $35.2M | ||
| Q3 25 | $378.0K | $34.6M | ||
| Q2 25 | $593.0K | $34.0M | ||
| Q1 25 | $1.2M | $33.6M | ||
| Q4 24 | $665.0K | $36.9M | ||
| Q3 24 | $1.7M | $35.8M | ||
| Q2 24 | $1.3M | $35.0M | ||
| Q1 24 | $898.0K | $35.3M |
净利润ABSINRC
| Q4 25 | $-29.6M | $1.8M | ||
| Q3 25 | $-28.7M | $4.1M | ||
| Q2 25 | $-30.6M | $-106.0K | ||
| Q1 25 | $-26.3M | $5.8M | ||
| Q4 24 | $-29.0M | $6.6M | ||
| Q3 24 | $-27.4M | $5.7M | ||
| Q2 24 | $-24.8M | $6.2M | ||
| Q1 24 | $-22.0M | $6.4M |
营业利润率ABSINRC
| Q4 25 | -4775.5% | 13.3% | ||
| Q3 25 | -7977.2% | 22.4% | ||
| Q2 25 | -5293.9% | 4.7% | ||
| Q1 25 | -2351.9% | 25.6% | ||
| Q4 24 | -4477.3% | 26.0% | ||
| Q3 24 | -1698.7% | 22.3% | ||
| Q2 24 | -2104.0% | 25.3% | ||
| Q1 24 | -2616.7% | 24.8% |
净利率ABSINRC
| Q4 25 | -4548.0% | 5.1% | ||
| Q3 25 | -7594.2% | 11.9% | ||
| Q2 25 | -5155.0% | -0.3% | ||
| Q1 25 | -2234.6% | 17.2% | ||
| Q4 24 | -4358.3% | 17.8% | ||
| Q3 24 | -1610.7% | 15.9% | ||
| Q2 24 | -1948.8% | 17.6% | ||
| Q1 24 | -2447.1% | 18.0% |
每股收益（稀释后）ABSINRC
| Q4 25 | $-0.19 | $49.58 | ||
| Q3 25 | $-0.20 | $0.18 | ||
| Q2 25 | $-0.24 | $-0.01 | ||
| Q1 25 | $-0.21 | $0.25 | ||
| Q4 24 | $-0.26 | $0.27 | ||
| Q3 24 | $-0.24 | $0.24 | ||
| Q2 24 | $-0.22 | $0.26 | ||
| Q1 24 | $-0.22 | $0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $144.3M | $4.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $189.4M | $14.0M |
| 总资产 | $216.3M | $134.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ABSINRC
| Q4 25 | $144.3M | $4.1M | ||
| Q3 25 | $152.5M | $2.2M | ||
| Q2 25 | $38.0M | $5.3M | ||
| Q1 25 | $47.0M | $2.5M | ||
| Q4 24 | $112.4M | $4.2M | ||
| Q3 24 | $38.2M | $3.5M | ||
| Q2 24 | $42.9M | $485.0K | ||
| Q1 24 | $58.8M | $1.7M |
总债务ABSINRC
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $4.0M | — | ||
| Q3 24 | — | $48.7M | ||
| Q2 24 | — | $33.3M | ||
| Q1 24 | — | $35.2M |
股东权益ABSINRC
| Q4 25 | $189.4M | $14.0M | ||
| Q3 25 | $210.3M | $14.3M | ||
| Q2 25 | $173.4M | $21.3M | ||
| Q1 25 | $198.8M | $29.7M | ||
| Q4 24 | $179.1M | $31.3M | ||
| Q3 24 | $201.3M | $34.6M | ||
| Q2 24 | $221.5M | $40.2M | ||
| Q1 24 | $240.1M | $36.9M |
总资产ABSINRC
| Q4 25 | $216.3M | $134.9M | ||
| Q3 25 | $245.0M | $135.7M | ||
| Q2 25 | $209.9M | $141.4M | ||
| Q1 25 | $232.4M | $135.2M | ||
| Q4 24 | $213.6M | $132.5M | ||
| Q3 24 | $235.2M | $131.8M | ||
| Q2 24 | $255.5M | $119.1M | ||
| Q1 24 | $274.9M | $120.9M |
负债/权益比ABSINRC
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.02× | — | ||
| Q3 24 | — | 1.41× | ||
| Q2 24 | — | 0.83× | ||
| Q1 24 | — | 0.95× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-29.2M | $7.2M |
| 自由现金流经营现金流 - 资本支出 | $-29.3M | $6.1M |
| 自由现金流率自由现金流/营收 | -4505.4% | 17.2% |
| 资本支出强度资本支出/营收 | 15.8% | 3.2% |
| 现金转化率经营现金流/净利润 | — | 3.99× |
| 过去12个月自由现金流最近4个季度 | $-94.2M | $15.7M |
8季度趋势，按日历期对齐
经营现金流ABSINRC
| Q4 25 | $-29.2M | $7.2M | ||
| Q3 25 | $-25.0M | $13.8M | ||
| Q2 25 | $-16.9M | $-1.1M | ||
| Q1 25 | $-21.8M | $6.6M | ||
| Q4 24 | $-17.0M | $6.4M | ||
| Q3 24 | $-20.7M | $9.4M | ||
| Q2 24 | $-16.8M | $6.8M | ||
| Q1 24 | $-17.9M | $12.0M |
自由现金流ABSINRC
| Q4 25 | $-29.3M | $6.1M | ||
| Q3 25 | $-26.0M | $10.2M | ||
| Q2 25 | $-17.1M | $-4.1M | ||
| Q1 25 | $-21.9M | $3.7M | ||
| Q4 24 | $-17.0M | $1.9M | ||
| Q3 24 | $-20.8M | $7.8M | ||
| Q2 24 | $-17.2M | $1.5M | ||
| Q1 24 | — | $7.9M |
自由现金流率ABSINRC
| Q4 25 | -4505.4% | 17.2% | ||
| Q3 25 | -6876.5% | 29.4% | ||
| Q2 25 | -2883.0% | -12.2% | ||
| Q1 25 | -1854.5% | 10.9% | ||
| Q4 24 | -2554.4% | 5.2% | ||
| Q3 24 | -1221.6% | 21.8% | ||
| Q2 24 | -1352.4% | 4.3% | ||
| Q1 24 | — | 22.4% |
资本支出强度ABSINRC
| Q4 25 | 15.8% | 3.2% | ||
| Q3 25 | 254.5% | 10.4% | ||
| Q2 25 | 37.6% | 8.8% | ||
| Q1 25 | 2.1% | 8.9% | ||
| Q4 24 | 3.5% | 12.0% | ||
| Q3 24 | 2.8% | 4.5% | ||
| Q2 24 | 26.2% | 15.0% | ||
| Q1 24 | 0.0% | 11.7% |
现金转化率ABSINRC
| Q4 25 | — | 3.99× | ||
| Q3 25 | — | 3.34× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.15× | ||
| Q4 24 | — | 0.97× | ||
| Q3 24 | — | 1.66× | ||
| Q2 24 | — | 1.10× | ||
| Q1 24 | — | 1.89× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
